Kenneth M. Ferguson

Insider Reports History

Location
Seattle, WA
Signature
/s/ Kenneth M. Ferguson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth M. Ferguson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cyclacel Pharmaceuticals, Inc. Director Common Stock 44,952 $149,016 $3.32 30 Jun 2023 Direct
Cyclacel Pharmaceuticals, Inc. Director Stock Option (right to buy) 42,438 30 Jun 2023 Direct

Insider Reports Filed by Kenneth M. Ferguson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CYCC Cyclacel Pharmaceuticals, Inc. 30 Jun 2023 2 $0 4 Director 03 Jul 2023, 16:56
CYCC Cyclacel Pharmaceuticals, Inc. 14 Jun 2022 2 $0 4/A Director 17 Jun 2022, 16:06
CYCC Cyclacel Pharmaceuticals, Inc. 14 Jun 2022 0 $0 3 Director 16 Jun 2022, 16:39